Skibsted Russell
- SEC CIK
- 0001308105
In the past year, 7 open-market purchase filings worth $41.7K and no sales.
Current role at each company
- PCSA Processa Pharmaceuticals, Inc.Chief Financial Officeras of Jul 28, 2026
- ALIM Alimera Sciences IncChief Financial Officer & SVPas of Nov 28, 2023
- RMTI Rockwell Medical, Inc.See Remarksas of Sep 13, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $41.7K
- 7 filings
- Sold
- –
- 0 filings
- Net
- +$41.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Skibsted Russell as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PCSA Processa Pharmaceuticals, Inc.
Chief Financial Officer7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 (view filing)4:17 PM ET | Jun 30 | 1 day | Skibsted RussellChief Financial Officer | PPurchase | +3.28K | $1.93 | +$6.32K | +24.4%16.7K after | |
| Jun 16, 2026 (view filing) | Jun 15 | 1 day | Skibsted RussellChief Financial Officer | PPurchase | +2.65K | $2.22 | +$5.89K | +24.7%13.4K after | |
| Jun 1, 2026 (view filing) | May 29 | 3 days | Skibsted RussellChief Financial Officer | PPurchase | +2.29K | $2.57 | +$5.89K | +27.1%10.8K after | |
| May 19, 2026 (view filing) | May 15 | 4 days | Skibsted RussellChief Financial Officer | PPurchase | +1.98K | $2.97 | +$5.89K | +30.6%8.47K after | |
| May 1, 2026 (view filing) | Apr 30 | 1 day | Skibsted RussellChief Financial Officer | PPurchase | +2.19K | $2.69 | +$5.89K | +50.8%6.50K after | |
| Apr 17, 2026 (view filing) | Apr 15 | 2 days | Skibsted RussellChief Financial Officer | PPurchase | +1.98K | $2.97 | +$5.89K | +85.4%4.31K after | |
| Apr 1, 2026 (view filing) | Mar 31 | 1 day | Skibsted RussellChief Financial Officer | PPurchase | +2.32K | $2.54 | +$5.90K | New position2.32K after |